0.930 CD

-0.005 (-0.53%)
Range 0.925 - 0.940   (1.62%)
Open 0.940
Previous Close 0.935
Buy Price 0.930
Buy Volume 7.6
Sell Price 0.935
Sell Volume 12.7
Volume 290.9
Value 270,881
Remark CD
Measurement Type Value
EPS (SGD) 0.033
Trailing EPS (SGD) 0.033
NAV (SGD) 0.46
Cash In Hand (SGD) 0.082
Dividend 0.025
Dividend Yield (%) 2.687
PE 28.216
Trailing PE 28.22
Price / NAV 2.023
Price / Cash In Hand 11.286
Issued & Paid-up Shares 1,828,912,000
Treasury Shares 400,000
Market Cap (M) 1,700.888
Par Value (SGD) n.a.
Beta - 75 Days 0.645
R-Squared - 75 Days(%) 39.45
Beta - 500 Days 0.509
R-Squared - 500 Days(%) 15.28
ISIN Code SG1CH4000003
Under CPF Investment Scheme (CPFIS) Yes
Index Components FTSE ST Mid Cap / FTSE ST All-share / FTSE ST Health Care / FTSE ST Large Mid Cap
Delayed prices. Updated at 09 Jul 2020 17:16.
Data powered by

Upcoming Events


Ex-Date 03 Aug 2020
Record Date 04 Aug 2020
Payable Date 16 Sep 2020
Declared Rate: SGD 0.02 per security/unit
Data powered by SGX.
View All Events

About Raffles Medical

Raffles Medical Group Ltd is an integrated healthcare provider, operating medical facilities in approximately 13 cities in Singapore, China, Japan, Vietnam and Cambodia. The principal activities of the Company are the operation of medical clinics and other general medical services. The Company's segments include Healthcare services, Hospital services and Investment holdings. The Healthcare services segment is engaged in the operations of medical clinics and other general medical services; provision of health insurance, trading in pharmaceutical and nutraceutical products and diagnostic equipment, and provision of management and consultancy services. The Hospital services segment is engaged in the provision of specialized medical services and operation of hospitals, and the business of medical laboratories and imaging centers. Its subsidiaries include Raffles Hospital Pte Ltd, Raffles Diagnostica Pte Ltd, Raffles Research Labs Pte Ltd and Raffles Chinese Medicine Pte Ltd.

Loading Chart...